95.0%
BNT162b2anti-PD-L1 therapy
…nity against pathogen antigens via mRNA-based vaccines, such as BNT162b2, significantly enhances cancer immunotherapy efficacy. Given wi…
5articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: BNT162b2 ×
BNT162b2
This drug is selected. Its supporting articles are shown below.
Articles mentioning BNT162b2
5 articles · page 1 of 178.7%
BNT162b2Ad26.COV2.Scovid-19Marburg virusEbola virus diseaseWorld Health Organizationmpox clade Ibviral haemorrhagic fever virusescovid-19-like
…om sub-Saharan Africa.1 For the lipid nanoparticle mRNA product BNT162b2 (Pfizer-BioNTech), 744 South African participants comprised 2% …
BNT162b2mRNA-1273myocarditisVAMheart transplantationBrighton Collaborationmechanical circulatory support
…ified all Norwegian residents who received at least one dose of BNT162b2 or mRNA-1273. By cross-linking registries, we identified myocar…
BNT162b2ChAdOx1mRNA-1273COVID-19multiple sclerosispwMSPfizer-BioNTechCOVID-19-relatedAstraZeneca/Oxford
…nd 449 healthy controls (HCs) who received at least one dose of BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna) or ChAdOx1 (AstraZeneca/…
BNT162b2Kawasaki diseaseMIS-C
…nd April 2022 despite previous immunisation against SARS-CoV-2 (BNT162b2, an mRNA vaccine against S-protein). Immunophenotyping, includi…